NGVT — Ingevity Corp
—
NYSE ·
Materials ·
Chemicals ·
CIK 1653477 ·
Last close
$68.53
Market Cap
$2.38B
52W High
$79.29
52W Low
$62.90
ADV30
239,327
Next earnings
2026-08-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 258,000,000 | 116,400,000 | 69,000,000 | 59,800,000 | 1,650,200,000 | 95,400,000 | 1,611,300,000 |
| Dec 2025 | 255,100,000 | 87,800,000 | 38,800,000 | -84,600,000 | 1,651,100,000 | 78,100,000 | 1,621,400,000 |
| Sep 2025 | 333,100,000 | 133,900,000 | 82,800,000 | 43,500,000 | 1,833,800,000 | 83,400,000 | 1,695,700,000 |
| Jun 2025 | 365,100,000 | 137,900,000 | 85,900,000 | -146,500,000 | 1,877,700,000 | 76,900,000 | 1,757,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$303,800,000
Investing CF
$60,300,000
Financing CF
$-303,000,000
CapEx
$-58,000,000
Dividends Paid
—
Buybacks
$-83,400,000
EPS Diluted TTM
$-3.55
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$464,700,000
Inventory
$203,600,000
Receivables
$151,200,000
ST Investments
—
EBIT TTM
$-82,400,000
Pretax Income TTM
$-155,700,000
Interest Exp TTM
$73,300,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,177,699,968
EBITDA
$360,600,000
Free Cash Flow
$225,800,000
Enterprise Value
$3,467,628,544
Total Cash
$95,400,000
Total Debt
$1,244,800,000
Shares Out
34,771,690
Trailing EPS
$-4.29
Book Value
$1.11
ROE
-114.1%
ROA
9.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,167,600,000 | 261,900,000 | -167,100,000 | 1,651,100,000 | 1,621,400,000 | — | 331,200,000 |
| Dec 2024 | 1,200,100,000 | 282,500,000 | -430,300,000 | 2,022,600,000 | 1,827,400,000 | — | 128,600,000 |
| Dec 2023 | 1,215,500,000 | 257,800,000 | -5,400,000 | 2,623,300,000 | 1,991,900,000 | — | 205,100,000 |
| Dec 2022 | 1,668,300,000 | 341,000,000 | 211,600,000 | 2,736,500,000 | 2,038,200,000 | — | 313,400,000 |
TTM Snapshot
Revenues TTM
$1,638,600,000
NetIncome TTM
$-10,800,000
OpCashFlow TTM
$0
Assets (Latest)
$2,022,600,000
Forward EPS
$5.75
Max Pain — expiry 2026-07-17 (volume-derived — Yahoo OI feed degraded)
max pain strike: $57.50 · spot: $68.53 · call volume: 13 · put volume: 40Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MTX | MINERALS TECHNOLOGIES INC | $2.42B | $78.11 | — |
| CURLF | Curaleaf Holdings, Inc. | $2.31B | $3.31 | — |
| DFTX | Definium Therapeutics, Inc. | $2.50B | $22.88 | — |
| PCT | PureCycle Technologies, Inc. | $2.22B | $12.27 | — |
| ROG | ROGERS CORP | $2.57B | $144.04 | — |
News headlines (Yahoo Finance, 1h cache)
Ingevity Q1 Earnings Call Highlights
2026-05-13 06:05 · Yahoo
NGVT Q1 Earnings Top Estimates on Pricing and FX Tailwinds
2026-05-12 14:40 · Yahoo
The Bull Case For Ingevity (NGVT) Could Change Following Q1 2026 Results And Portfolio Reshaping Steps
2026-05-09 20:13 · Yahoo
Ingevity Corporation Q1 2026 Earnings Call Summary
2026-05-07 12:30 · Yahoo
Ingevity (NGVT) Beats Q1 Earnings and Revenue Estimates
2026-05-06 22:30 · Yahoo
Ingevity reports first quarter 2026 financial results
2026-05-06 20:15 · Yahoo
Ingevity Stockholders Approve All Proposals at 2026 Annual Meeting; CEO Targets $1B Deployable Cash
2026-05-03 18:05 · Yahoo
Assessing Ingevity (NGVT) Valuation After A Strong Year Of Shareholder Returns
2026-04-30 15:09 · Yahoo
How The Investment Story For Ingevity (NGVT) Is Quietly Shifting With New Assumptions
2026-04-29 12:04 · Yahoo
RBC Capital Bullish on PPG Industries (PPG) – Raises Price Target
2026-04-21 19:26 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.